Holding(s) in Company

Allergy Therapeutics PLC
06 January 2005


                                  Schedule 10

                    NOTIFICATION OF MAJOR INTERSTS IN SHARES

1.      Name of Company

        Allergy Therapeutics plc

2.      Name of shareholder having a major interest

        Baillie Gifford & Co.

3.      Please state whether notification indicates that it is in
respect of holding of the shareholder names in 2 above or in respect of a
non-beneficial interest or in the case of children under the age of 18

.........................................................

4.      Name of the registered holder(s) and, if more than one
        holder, the number of share held by each of them

         RBS Dep Bg British Sml Co Fd (oeic) under BNY (OCS) Nominees Limited

5.      Number of shares/amount of stock acquired

        2,054,795

6.      Percentage of issued class

       3.26%

7.     Number of shares/amount of stock disposed

       .........................................................

8.     Percentage of issued class

       .........................................................

9.     Class of security

       Ordinary Shares

10.     Date of transaction

        12/10/2004


11.     Date company informed

        04/01/2005

12.     Total holding following this notification

        2,054, 795

13.     Total percentage holding of issued class following this
        notification

        3.26%

14.     Any additional items

         ........................................................

15.     Name of contact and telephone number for queries

        Ian Postlethwaite - 01903 844721

16.     Name and signature of authorised company official responsible
        for make this notification

        Ian Postlethwaite ..............................................

Date of notification

06/01/2005

The FSA does not give any express or implied warranty as to the accuracy of this
document or material and does not accept liability for error or omission. The
FSA is not liable for any damages (including, without limitation, damages for
loss of business or loss of profits) arising in contract, tort or otherwise from
the use of or inability to use this document, or any material contained in it,
or from any action or decision taken as a result of using this document or any
such material.






                      This information is provided by RNS
            The company news service from the London Stock Exchange